Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BCAB is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
3 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 7
21 filers reported a long position in BCAB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
Q1 2026 shares are adjusted for the 2026-04-06 1-for-50 reverse split.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ACORN CAPITAL ADVISORS, LLC | $447.6K | 108.1K | 0% |
| MILLENNIUM MANAGEMENT LLC | $292.4K | 70.6K | +28.1% |
| Lido Advisors, LLC | $69K | 16.7K | New |
| Stonepine Capital Management, LLC | $68K | 16.4K | +1,156.5% |
| ACADIAN ASSET MANAGEMENT LLC | $58K | 14.3K | -42.1% |
| HRT FINANCIAL LP | $54K | 13.3K | New |
| GEODE CAPITAL MANAGEMENT, LLC | $53.1K | 12.8K | -7% |
| DEUTSCHE BANK AG\ | $43.7K | 10.6K | +0.5% |
| BlackRock, Inc. | $39.8K | 9.6K | 0% |
| VANGUARD CAPITAL MANAGEMENT LLC | $37.9K | 9.2K | -72.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.